Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000919574-25-001872·Casdin Capital, LLC
Schedule 13D ownership disclosure
Tenaya Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 87990A106
Event date: 2025-03-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Casdin Capital, LLCReported CIK 0001534261
Shares: 6,732,971.00 · Class: 4.3%
- Casdin Partners Master Fund, L.P.Reported CIK 0001534265
Shares: 6,371,002.00 · Class: 4.1%
- Casdin Partners GP, LLCReported CIK 0001534260
Shares: 6,371,002.00 · Class: 4.1%
- Eli CasdinReported CIK 0001534264
Shares: 6,732,971.00 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001872
- Form type
- SCHEDULE 13D/A
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Mar 07, 2025
- Reporting period
- Mar 04, 2025
- Description
- Schedule 13D beneficial ownership